More stories
-
Many Cancers Outperform National Survival Rates at CU Cancer Center
UCHealth’s CU Cancer Center boasts higher five-year cancer survival rates National Cancer Survivors Day For many cancer patients, survival rates are a crucial measure of success. On National Cancer Survivors Day, the University of Colorado Cancer Center is honored to celebrate cancer survivors while highlighting a positive trend in survival rates for those treated at […] More
-
ASCO Novel CAR T Therapy and Shorter Targeted Treatment EurekAlert
Novel CAR T cell therapy Obe-cel Yields Strong Remission Rates in Adults with Relapsed or Refractory B-ALL Introduction The Phase Ib/II FELIX clinical trial results demonstrated that the anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obe-cel is an effective and safe treatment option for adults with relapsed or refractory B-cell acute lymphoblastic leukemia […] More
-
COVID-19 and Vision Damage: A Alarming Discovery by Managed Healthcare Executive
The Eye and COVID-19: What We Know From Recent Research Introduction The COVID-19 pandemic has affected millions of people worldwide and continues to present new challenges to public health. In this article, we will discuss recent research findings regarding COVID-19 and the eye, as well as other important topics related to eye health. New Research […] More
-
Increasing Cancer Clinical Trial Participation Among Minority Communities
Improving Racial and Ethnic Diversity in Cancer Clinical Trials Racial and ethnic diversity in cancer clinical trials remains critically low, significantly impacting the applicability and effectiveness of medical research across different populations. Kimberley Lee, MD, a medical oncologist in Moffitt Cancer Center’s Department of Breast Oncology, aims to address this issue by understanding patient attitudes […] More
-
“Thyroid Eye Disease Patients See Long-Term Benefits with Teprotumumab Infusions”
Thyroid Eye Disease Patients Maintain Improvement Two Years After Teprotumumab Infusions A recent industry-supported study presented at ENDO 2024 and published in the journal Thyroid shows that most patients with thyroid eye disease treated with teprotumumab usually don’t require additional treatments nearly two years later. Thyroid eye disease is an autoimmune disease that affects the […] More
-
Decoding Superior Mesenteric Artery Syndrome: Causes, Signs, Detection and More
Alternative Medicines and Healthcare Treatments The Importance of Integrative Medicine Integrative or complementary medicine is a vital component in healthcare, which centers on the principle of treating the whole body, including physical, emotional, and social well-being. The objective of integrative medicine is to provide every possible chance for healing while remaining open to various holistic […] More
-
Leads Biolabs Unveils LBL-024, a Game-Changing Anti-Cancer Treatment!
Leads Biolabs’ Innovative Cancer Treatment LBL-024 Achieves Outstanding Phase II Results at 2024 ASCO Annual Meeting The annual meeting of the American Society of Clinical Oncology (ASCO) commenced on May 31st, 2024, showcasing groundbreaking cancer research from around the world. Over 7,000 abstracts were submitted this year, with LBL-024, a bispecific antibody independently developed by […] More
-
Indulgent Escape: The Spa at Mandarin Oriental London on Vogue
The Mandarin Oriental Mayfair: A Comprehensive Approach to Wellness The Mandarin Oriental Mayfair’s spa is a sleek and stylish urban sanctuary located in London’s West End. It has been designed as a comprehensive approach to supporting physical and mental well-being, integrating biohacking techniques with relaxing methods in the treatments on offer. Read on to learn […] More
-
Preliminary Analysis Reveals Promising Results for Investigational Epcoritamab DuoBody: Morningstar
Epcoritamab potentially provides promising results for patients with follicular lymphoma Overview Follicular lymphoma (FL) is the second most common form of non-Hodgkin’s lymphoma (NHL). Approximately 15,000 individuals develop FL each year in the United States, accounting for 20-30% of all NHL cases. FL is considered incurable with present standard of care therapies, and patients often […] More
-
Exacerbated MALS Symptoms After Surgery? There’s a Treatment for That!
Integrative Medicine: Understanding the Benefits and Drawbacks What is Integrative Medicine? Integrative medicine is a discipline that combines conventional medical treatments with complementary and alternative therapies to promote healing and overall wellness. It focuses on treating the whole person, rather than solely focusing on symptoms or illnesses. It includes a variety of practices, such as […] More
-
Study Uncovers Inequalities in Cancer Care at Minority Hospitals
Study Finds Significant Disparities in Cancer Treatment at Minority Serving Hospitals Introduction Providing high-quality care to all patients, regardless of race or ethnicity, should be a top priority of US hospitals. However, new research published in CANCER, a peer-reviewed journal of the American Cancer Society, reveals significant disparities in the delivery of cancer-related care at […] More
-
Revolutionary drug testing techniques: Vascularized organ-on-a-chip glimpses the future
Vascularized Organ-on-a-Chip Systems: Revolutionizing Medical Research Medical research is evolving rapidly, and thanks to the advancements in biomedical engineering, a groundbreaking development is currently set to revolutionize the way we approach drug testing and disease modeling. Organ-on-a-chip technology mimics human organs on a microscale by cultivating cells in a controlled microenvironment that simulates the 3D […] More
-
Landmark Lung Cancer Studies Set to Alter Standard of Care Moffitt
Lung Cancer Treatment Advancements Lung cancer remains one of the most fatal cancers worldwide. According to the American Cancer Society, lung cancer is the second most common cancer in both men and women, accounting for about 13% of all new cancer diagnoses. Several thousand new cases are diagnosed each year. However, new research presented at […] More
-
Unraveling the Impact of Tumor Microenvironment on DLBCL Prognosis and Treatment
Understanding the Tumor Microenvironment in Diffuse Large B-Cell Lymphoma (DLBCL) Introduction Diffuse large B-cell lymphoma (DLBCL) is a complex disease, both in terms of its genetic makeup and the role of the tumor microenvironment (TME) in its development and progression. Research into these aspects of DLBCL has shown great promise in terms of developing more […] More
-
Genmab’s Innovative Therapies to Revolutionize Lymphoma Treatment Landscape
Genmab’s Promising Clinical Data and Strong Pipeline Position Them as a Leader in Oncology Background on Genmab A/S Genmab A/S is a global biotech company dedicated to developing unique antibody therapeutics to treat cancer. Their monoclonal antibody products, DARZALEX and Arzerra, are currently used to treat patients with multiple myeloma and chronic lymphocytic leukemia, respectively. […] More
-
Hot
Digital cancer care startup lays off staff
Virtual Cancer Care Startup Jasper Health Lays Off Staff Virtual cancer care startup Jasper Health has laid off staff, as reported by TechCrunch. The company reportedly had around 48 employees before making cuts that may have affected up to half of its workforce, according to a May 31 article. Jasper Health’s Offering Jasper Health offers […] More
Load More
Congratulations. You've reached the end of the internet.